Documents

Ideas Discussions Technicals Forecast Seasonals Options

Dianthus Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Dianthus Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Study Result

Sep 08, 2025

Transcript

Slides

Press release

Q2 2025

Aug 07, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 12, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 06, 2025

Transcript

2024

Q4 2024

Mar 11, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Earnings release8-K

Q2 2024

Aug 08, 2024

Earnings release8-K

Q1 2024

May 09, 2024

Earnings release8-K

Corporate Presentation

Mar 14, 2024

Slides

2023

Q4 2023

Mar 21, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 09, 2023

Earnings release8-K

M&A Announcement

May 03, 2023

Press release

2022

Q4 2022

Mar 23, 2023

Annual report10-K

Q3 2022

Nov 03, 2022

Earnings release8-K

Q2 2022

Aug 04, 2022

Earnings release8-K

Q1 2022

May 16, 2022

Earnings release8-K

2021

Q4 2021

Mar 08, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 04, 2021

Earnings release8-K

Q2 2021

Aug 05, 2021

Earnings release8-K

Q1 2021

May 06, 2021

Earnings release8-K

2020

Q4 2020

Mar 03, 2021

Annual report10-K

2019

Q4 2019

Mar 03, 2020

Annual report10-K

2018

Q4 2018

Mar 19, 2019

Annual report10-K